小鼠胚胎干细胞R1表面特异结合多肽的筛选

胚胎干细胞是从哺乳动物胚胎发育早期的囊胚的内细胞团内分离出来的一类细胞,具有自我更新和全能性的基本特征.作者利用M13噬菌体展示技术筛选与未分化的小鼠胚胎干细胞R1表面特异结合的多肽.实验利用未分化的小鼠胚胎干细胞为筛选靶细胞,分化的小鼠胚胎干细胞为吸附细胞,进行3轮的消减筛选,经细胞ELISA鉴定,噬菌体DNA测序和多肽序列分析,得到13条能与小鼠胚胎干细胞特异结合的多肽.通过BLASTP比对发现有11个体内的同源蛋白,为进一步研究小鼠胚胎干细胞表面分子提供研究基础.     

HPV-58型E7蛋白抗原模拟表位的筛选及分析

利用该实验室成熟的噬菌体随机十二肽库筛选平台,对HPV-58型E7蛋白单克隆抗体株4C4a、6C7a进行3轮亲和筛选,得到2组、各8个阳性噬菌体克隆.阳性噬菌体氨基酸序列用以模拟单抗(靶蛋白)特异性识别的HPV-58型E7蛋白的抗原表位.将测得的阳性噬菌体多肽序列及HPV-58型E7蛋白氨基酸序列进行生物信息学分析后,进行线性序列比对及构象性表位预测及分析.构象性表位的预测借力于EpiSearch Server和Pepitope Server,对构象性表位匹配及簇的寻找提供有力支持,也为早期诊断及研制多肽疫苗提供参考.     

Cε3-Cε4结合肽筛选及鉴定

为了获得免疫球蛋白E(IgE)特异性结合肽,采用固相筛选法,以Cε3-Cε4为靶蛋白,利用噬菌体随机多肽展示技术进行筛选,4轮筛选后,经ELISA鉴定获得19个阳性单克隆噬菌体,阳性率达38％,测序并翻译后共获得11个结合肽.竞争抑制性实验证明P7,P13,P20与Cε3-Cε4蛋白的结合能力较强,细胞水平分析表明:结合肽P7,P20可阻止IgE与其受体结合.本研究将为进一步探索IgE结合肽生物学功能奠定基础,并为设计治疗变态反应性疾病的小分子药物提供参考.     

噬菌体展示技术筛选布鲁氏菌OMP25特异性结合肽

利用噬菌体展示技术和ELISA筛选与布鲁氏菌外膜蛋白OMP25结合的七肽分子.将纯化的OMP25-32a包被于聚乙烯板上,对随机噬菌体七肽库进行4轮筛选后挑取噬菌体克隆,ELISA鉴定噬菌体克隆对OMP25-32a的亲和力和特异性.并将阳性噬菌体克隆扩增、测序、获得多肽氨基酸序列,生物信息分析筛选出特异的环形七肽分子.结果从噬菌体七肽库中筛选出42个噬菌体阳性克隆,测序翻译得到对应的42个环形七肽分子;ELISA结果表明,42个噬菌体中9#、11#、35#、38#和41#与融合蛋白OMP25-32a具有较强的亲和性;生物信息学分析42个环形七肽分子中11#环形七肽与锌指蛋白ZNF446有高度同源性.筛选获得了与布鲁氏菌外膜蛋白OMP25相互作用的环形七肽分子LT-7C,为进一步研究抗布鲁氏菌病的药物治疗提供科学依据.     

sFcγRⅡb蛋白结合肽的筛选与鉴定

FcγRⅡb是免疫球蛋白G受体( FcγR)中唯一的抑制型受体,在免疫反应的负性调节方面发挥重要作用.为了筛选sFcγRⅡb的蛋白结合肽,以重组sFcγRⅡb蛋白为靶分子,采用噬菌体肽库展示技术对sFcγRⅡb结合肽进行筛选.利用ELISA鉴定每轮洗脱噬菌体与sFcγRⅡb蛋白亲和力,经过4轮筛选,挑取40个噬菌体克隆进行序列测定,获得28种不同的12肽序列.经ELISA法鉴定噬菌体与sFcγRⅡb蛋白结合活性,得到sFcγRⅡb蛋白高特异性、高亲和力结合肽FHKMPWYMSMYY,为进一步研究FcγRⅡb的作用机制和探索结合肽的功能提供实验基础.     

燕麦多肽数据库及降血糖活性的虚拟筛选

为了深入研究燕麦多肽中可能发挥降血糖功能的活性多肽分子，本文首先从文献中调研了从燕麦中提取鉴定得到的多肽，构建了对应的燕麦多肽数据库，并基于DPP4蛋白对多肽数据库进行了虚拟筛选.随后，针对筛选获得的6个多肽分别进行了100 ns的分子动力学模拟.从模拟之后稳定结合的构象分析了不同多肽分子与DPP4的相互作用信息，并分别计算了不同多肽分子与DPP4的结合自由能.结果表明，从燕麦多肽数据库中筛选得到的多肽可以与DPP4蛋白稳定结合，其中2个多肽分子与DPP4的亲和力相对较强.本文得到的多肽分子可以作为后续DPP4抑制剂设计和改造的先导分子，燕麦多肽数据库也可用于研究燕麦的其他生物学功能.     

高低危型HPV E7的分析以及58型E7结构与结合位点预测

 对18种HPV E7蛋白进行生物信息学分析,同时对HPV58 E7进行结构以及可结合位点的预测.从NCBI数据库中获取蛋白序列,通过ExPASy Protparam进行生物信息分析,Clustal W进行多序列比对,MEGA软件构建进化树,利用Zhang lab QUARK以及Q-SiteFinder能量依赖的检测对HPV58 E7进行结构预测与结合位点预测.得到了E7生物信息,多序列比对数据,构建成进化树,获得HPV58 E7蛋白结构,并且找到pRb与E7结合的三维位点.不同类型HPV E7蛋白存在进化差异,得到的HPV58型结构以及与pRb的可以结合位点,为抑制HPV58 E7蛋白功能的相关实验提供了理论依据.     

赤点石斑鱼MHC IA基因的克隆与表达多态性分析

采用RACE技术,成功克隆获得赤点石斑鱼(Epinephelus akaara)非特异性免疫因子MHC IA基因的4个cDNA全序列,序列全长为1 680bp,含有3′UTR、启动子、多肽结合区(α1)、IGC区(α2)、跨膜区、胞质区和5′UTR区,编码区大小为1 074～1 080bp,共编码357～359个氨基酸,推测蛋白质分子质量约41.66ku.氨基酸序列分析发现赤点石斑鱼MHC IA分子具有经典MHC蛋白分子的空间结构,在多肽结合区则存在极其丰富的变异.利用Real time PCR和SSCP技术研究了赤点石斑鱼MHC IA的组织表达特异性和表达多态性,发现其在头肾、心、肝等12个组织器官中均能有效表达,在头肾,脾,胸腺等免疫组织表达量不仅高,表达多态性也异常丰富,而在与外界环境接触较多的鳃、肌肉、肠等组织表达较弱.此外,根据MHC IIB分子中相对保守的IGC区氨基酸序列构建了脊椎动物的系统进化树,也表明了该分子的IGC区氨基酸序列可以作为研究鱼类物种间进化关系的良好标记.     

异柠檬酸裂解酶肽类抑制剂的优化筛选

利用噬菌体肽库筛选与计算机模拟分子对接技术, 优化异柠檬酸裂解酶肽类抑制剂的筛选. 先通过噬菌体肽库筛选出与异柠檬酸裂解酶（ICL）具有高亲和力的结合肽, 再利用Discovery Studio 2.1模拟多肽与ICL蛋白晶体（1F8I）的分子对接, 最后用Fmoc固相合成法合成多肽, 并对其生物活性进行检测. 实验结果表明, 通过噬菌体肽库筛选得到了29条七肽序列, 其中12条可与ICL蛋白晶体成功对接. 体外生物活性检测结果显示, 得到的12条七肽均对ICL的活性有明显抑制作用（抑制率均超过50%）.     

多肽序列优化降低c-Src蛋白靶向药物的毒性风险

避免c-Src蛋白的多肽类拮抗剂与多个蛋白发生混杂性结合,对于降低抗癌药物的毒性风险具有重要作用。本研究运用生物信息学方法对氨基酸序列进行优化设计,旨在减少混杂性结合的发生。本研究综合利用各种多肽数据库和生物信息学工具,首先总结了多肽分子与多个蛋白SH3结构域之间潜在的混杂性结合,并发现了其中的内在规律。随后,根据所发现的规律,对多肽的氨基酸序列进行针对性的优化设计。结果表明,大多数多肽在经过优化后,所结合的c-Src以外的蛋白数量都有所下降,从而显著提高了多肽与c-Src蛋白之间结合的特异性(P0.05),并降低了其潜在的毒性风险。本研究所取得的结果将为设计具有高度特异性和低毒性的靶向性多肽药物提供参考。     

The E. coli ffh gene is necessary for viability and efficient protein export.

Homologues of the gene encoding the 54K (M(r) 54,000) subunit of the mammalian signal recognition particle have been identified in different organisms. The Escherichia coli homologue, termed ffh (for fifty-four homologue), specifies a protein (Ffh) that shares many properties with its eukaryotic counterpart, including association with mammalian 7S RNA and the ability to bind signal sequences specifically. Ffh also associates with E. coli 4.5S RNA, showing that it can form a ribonucleoprotein complex in prokaryotes. These results are intriguing because extensive genetic and biochemical characterization of E. coli failed to identify a signal recognition particle-like mechanism for protein export. Here we address this issue directly by construction of a strain in which ffh expression is arabinose-dependent. Results of depletion experiments indicate that Ffh is important in protein translocation.     

58型人乳头瘤病毒E7蛋白单克隆抗体的制备及鉴定

 为获得抗58型人乳头瘤病毒(HPV58)E7蛋白的单克隆抗体,乳糖诱导重组工程菌表达HPV58 E7融合蛋白,以纯化后的该重组蛋白为免疫原,经细胞融合和有限稀释后,得到6株分泌抗HPV58 E7单克隆抗体(McAb)的工程细胞株,并采用体内接种方法及亲和柱层析纯化技术制备6株抗体.酶联免疫吸附测定(ELISA)、Western-blot实验和细胞免疫荧光检测结果表明,所得抗体均为IgG2a类,κ型,抗体效价均可达10^-5,并且能够与原核及真核系统表达的HPV58 E7蛋白发生特异性抗原-抗体反应.该抗体的成功制备为后续HPV58 E7致癌生物学研究及相关肿瘤诊断试剂的开发奠定基础.     

Homologous expressed genes in the human sex chromosome pairing region

The human sex chromosomes share a pair of homologous genes which independently encode a cell-surface antigen defined by the monoclonal antibody 12E7 (refs 1, 2; see refs 3, 4 for review). The X-located homologue, MIC2X, escapes X-inactivation and the equivalent Y-located locus, MIC2Y, was one of the first genes shown to reside on a mammalian Y chromosome. By using a bacterial expression system we have previously cloned a complementary DNA sequence corresponding to a MIC2 gene and have used this probe to show that the MIC2X and MIC2Y loci are closely related, if not identical. Here we report the use of the cloned probe to confirm the localization of the MIC2X locus to the region Xpter-Xp22.32 (ref. 7) and demonstrate, for the first time, that the MIC2Y locus is located on the short arm of the Y chromosome in the distal region Ypter-Yp11.2. The MIC2 sequences and the sequences described in the accompanying papers by Cooke et al. and Simmler et al. are the first which have been shown to be shared by the sex chromosomes in the pairing region.     

Inhibitory effect of the adenovirus type 5 E1A protein expressed in the yeast system

The human adenovirus type 5 E1A, a tumor- suppressor gene[1], codes for two major related proteins of 243 amino acids (12S) and 289 amino acids (13S) by al-ternative splicing in two exons[2]. Studies have been shown that E1A can regulate expression of many genes and cell cycle[3]. Both in vitro and in vivo experiments indicated that E1A could induce tumor cells differentia-tion, convert tumor cells into an epithelial phenotype, in-hibit tumor cell growth and metastasis and strongly en-ha…     

Inhibitory effect of the adenovirus type 5 E1A protein expressed in the yeast system on the human tumor cell growth

Adenovirus 5 type E1A as a tumor suppressor gene can inhibit tumor growth and enhance the sensitivity of chemotherapy and radiotherapy. E1A have the ability to integrate into the host genome, resulting in long-time expression that induces Rb gene inactivation and animal cells immortalization. This prompted us to select the E1A protein for treatment of cancer in order to overcome the limitations of E1A gene therapy. Thus, we firstly constructed E1A eucaryotic expression vector (pPIC9/E1A), transformated the pichia pastoris yeast cells (GS115) and screened the high-expressing recombinant strains. The positive yeast strains were cultured in the shake flask, and induced for 3 d. The crude E1A protein was purified using two steps of column chromatography on HiTrap Q and HiTrap SP. The purified E1A protein was identified by SDS-PAGE and Western blot. E1A protein was mostly located at cellular nuclear when Chariot delivered E1A protein into cells. The analysis in vitro indicated that the E1A protein arrested LN686 cell cycle at G2/M phase, and significantly inhibited the growth of LN686 tumor cells. The current studies firstly provided an experimental basis to further develop E1A protein for tumor treatment.     

Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product

The E7 transforming protein of human papilloma virus-16 binds to the retinoblastoma gene product (pRb) through a nine-amino-acid segment of E7 (21-29). This segment of E7 is homologous to the pRb-binding domains of the simian virus 40 large T and adenovirus E1A transforming proteins. Each of these viral transforming proteins bind to the same region of pRb. To isolate cellular proteins that interact with this viral protein-binding domain on pRb, we used recombinant pRb to screen a human complementary DNA expression library. Two cDNAs were isolated that encode retinoblastoma binding proteins (RBP-1 and RBP-2). We report here that these RBP genes exist in separate loci and produce discrete messenger RNAs. The predicted amino-acid sequence of these genes showed no homology to known proteins, but both RBPs contain the pRb binding motif conserved between E7, large T and E1A14. In vitro expression of the RBP cDNAs yielded proteins that specifically bound to pRb. Recombinant E7 protein, the E7 21-29 peptide and the homologous RBP-1 peptide inhibited RBP-pRb binding. Mutations introduced into the putative pRb-binding segment in RBP-1 impaired its binding activity. These studies indicate that the cellular RBP-1, RBP-2 and viral E7 proteins interact with pRb through similar domains.